NAMPT Inhibitors Market is driven by oncology applications

adicionou um novo artigo Health

2025-05-16 10:31:15 -

NAMPT inhibitors are a class of small-molecule therapeutics targeting nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in NAD+ biosynthesis that supports rapidly proliferating cancer cells. By inhibiting NAMPT, these compounds induce metabolic stress and apoptosis in tumor cells, offering a novel mechanism distinct from traditional chemotherapies. NAMPT Inhibitors Market Advantages...

0 Comentários 0 Compartilhamentos 586 Visualizações 0 Anterior